Stay updated on Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial page.

Latest updates to the Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial page
- Check6 days agoChange DetectedRecord history now indicates that the study is no longer looking for participants, signaling that enrollment has ceased. The entry also updates the record version to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.4%

- Check13 days agoChange DetectedThe page shows a new software revision label, updating from v3.5.4 to v3.5.5. This indicates a platform-level release for the history view rather than changes to the study record itself.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedRecord History now includes an administrative closure and termination, with new entries indicating Results Posted and updated study sections. Added sections cover Adverse Events, Baseline Characteristics, Outcome Measures, Participant Flow, and other core documentation.SummaryDifference2%

- Check49 days agoChange DetectedThe Record History now includes a new revision entry (v3.5.3) and removes the prior revision (v3.5.2). This reflects an update to the study record's revision metadata.SummaryDifference0.1%

- Check56 days agoChange DetectedThe number of “Results Submission Events” shown in the record history increased from 3 to 4, reflecting an additional results-submission event entry. This does not indicate a change to the substantive study details themselves.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision v3.5.2 was added to the history and revision v3.5.0 was removed from the history.SummaryDifference0.1%

Stay in the know with updates to Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial page.